Eagle Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-36,042
| Closed | -$2.23M | – | 563 |
|
|
2023
Q4 | $2.23M | Sell |
36,042
-1,659
| -4% | -$103K | 0.01% | 443 |
|
|
2023
Q3 | $1.73M | Sell |
37,701
-31,888
| -46% | -$1.47M | 0.01% | 447 |
|
|
2023
Q2 | $4M | Sell |
69,589
-237,181
| -77% | -$13.6M | 0.02% | 380 |
|
|
2023
Q1 | $11.5M | Buy |
306,770
+5,897
| +2% | +$221K | 0.07% | 230 |
|
|
2022
Q4 | $8.48M | Sell |
300,873
-9,382
| -3% | -$265K | 0.05% | 261 |
|
|
2022
Q3 | $8.72M | Buy |
310,255
+82,796
| +36% | +$2.33M | 0.06% | 254 |
|
|
2022
Q2 | $7.91M | Buy |
227,459
+50,120
| +28% | +$1.74M | 0.05% | 281 |
|
|
2022
Q1 | $6.37M | Sell |
177,339
-74,277
| -30% | -$2.67M | 0.03% | 353 |
|
|
2021
Q4 | $5.82M | Sell |
251,616
-33,002
| -12% | -$764K | 0.03% | 387 |
|
|
2021
Q3 | $5.41M | Sell |
284,618
-19,856
| -7% | -$377K | 0.02% | 391 |
|
|
2021
Q2 | $6.14M | Sell |
304,474
-5,985
| -2% | -$121K | 0.03% | 391 |
|
|
2021
Q1 | $5.62M | Sell |
310,459
-1,964
| -0.6% | -$35.5K | 0.02% | 399 |
|
|
2020
Q4 | $6.28M | Buy |
312,423
+28,179
| +10% | +$567K | 0.04% | 361 |
|
|
2020
Q3 | $5.3M | Sell |
284,244
-16,974
| -6% | -$316K | 0.03% | 358 |
|
|
2020
Q2 | $6.66M | Sell |
301,218
-16,770
| -5% | -$371K | 0.04% | 336 |
|
|
2020
Q1 | $4.72M | Buy |
317,988
+33,752
| +12% | +$501K | 0.03% | 367 |
|
|
2019
Q4 | $5.48M | Buy |
+284,236
| New | +$5.48M | 0.03% | 396 |
|